• Biosimilars Match Up With Originals for Skin Disorders

    9 days ago - By MedPageToday

    A mandated, nonmedical switch from adalimumab to a biosimilar for psoriasis did not lead to a drop-off in drug retention, according to a Danish registry analysis.
    A year after switching to a biosimilar, 92.0% of patients...
    Read more ...